One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...

NYC- and Paris-based DeepIP reaches $40M in total funding, with tenfold ARR growth in 18 months, as workflow-native AI becomes the standard for modern patent operations. $25M Series B co-led by tech ...

The workflow-native platform brings total funding to $40 million as leading firms adopt its end-to-end infrastructure for ...

DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...

The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...

The "Glucose Goddess" built a brand around her blood sugar balancing hacks. She said a few swaps to her diet boosted her mood ...

The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

Leach succeeds Abbott EVP of Diabetes Care, Chris Scoggins, in the position. Eric Benjamin, Insulet’s EVP and COO, will serve as the vice chair for the medical device industry association’s Diabetes ...

Senseonics rolls out Eversense 365 integrated with Sequel's twiist AID system, aiming to boost CGM adoption with its ...

In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

The S&P 500 closed barely higher Feb. 13, with technology and communications services down on nagging fears of AI-disruption but equities drew support from optimism that cooling ...

Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don’t take insulin. New CEO Jake Leach told investors on Thursday that the ...